# Larry Wang

> Larry (Luquan) Wang is the co-founder, co-CEO and CTO of Vibrant Therapeutics and a co-founder of GenScript. Educated at Shandong University and Rutgers, he worked at Schering-Plough before serving as president of GS Corp from 2003 to 2014. His career spans computational research, technical systems and company leadership.

- **Role:** Co-Founder, Co-CEO & CTO at Vibrant Therapeutics
- **Organizations:** Vibrant Therapeutics, GenScript, GS Corp, Schering-Plough Research Institute, Rutgers University
- **Education:** BS in Biochemistry, Shandong University, PhD, Rutgers University
- **Known for:** Co-founded GenScript in 2002., Served as president of GS Corp for 2003-2014., Co-founded Vibrant Therapeutics in 2019.

## Career timeline

- **1991** — Completed his biochemistry degree at Shandong University and began graduate research at Rutgers.
- **1995-1996** — Worked in bioinformatics at Rutgers.
- **1996-2003** — Worked as a senior principal scientist at Schering-Plough Research Institute.
- **2002** — Co-founded GenScript with Frank Zhang and Sally Wang.
- **2003-2014** — Served as president of GS Corp.
- **2015** — Appointed a GenScript director in May and redesignated a non-executive director in August.
- **2019** — Founded Vibrant Therapeutics.
- **2020** — Appointed CEO and chairman of Vibrant Pharma Ltd. in December.
- **2025** — Resigned from GenScript’s non-executive board effective May 29.
- **2026** — Vibrant announced $61 million in new financing and Han Lee’s appointment as co-CEO alongside Wang.

## Achievements

- Co-founded GenScript in 2002.
- Served as president of GS Corp for 2003-2014.
- Co-founded Vibrant Therapeutics in 2019.
- Vibrant announced $61 million in new financing in January 2026, bringing total capital raised to $100 million.
- GenScript’s Chief Bioinformatics System Architect, according to his Vibrant biography.

## Latest updates

- **2026-06** — BIO International Convention’s company presentation listing identified Larry Wang and Han Lee as Vibrant’s CEOs; Leon Wert-Lamas was the primary speaker.
- **2026-01** — Vibrant announced $61 million in new financing, total capital raised of $100 million and Han Lee’s appointment as co-CEO.
- **2025-05** — Resigned from GenScript’s non-executive board effective May 29.

## Links

- Website: https://vibrantx.com/
- LinkedIn: https://www.linkedin.com/in/larry-wang-237166b/

---

Profile page: https://yespress.io/larry-wang
Published by YesPress — https://yespress.io
Last updated: 2026-10-12